Impact of medication reconciliation for patients enrolled in oncology early phases clinical trials: A drug-drug interactions retrospective study

被引：1
|
作者：
Malifarge, L. [1 ]
Deppenweiler, M. [1 ]
Italiano, A. [2 ]
Lortal, B. [1 ]
机构：
[1] Inst Bergonie, Pharm, Bordeaux, France
[2] Inst Bergonie, Early Phase Trials Unit, Bordeaux, France
来源：
ANNALS OF ONCOLOGY | 2020年 / 31卷
关键词：
D O I：
10.1016/j.annonc.2020.08.1489
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1842P
引用
收藏
页码：S1057 / S1057
页数：1
相关论文
共 50 条
  • [21] Retrospective Study on Prevalence and Clinical Significance of Possible Drug-Drug Interactions in Prescriptions of Patients with Chronic Liver Disease
    Shamim, Sumbul
    Fareed, Sharjeel
    Ali Masood, Muhammad
    Arshad, Muhammad
    Gul, Huma
    LATIN AMERICAN JOURNAL OF PHARMACY, 2018, 37 (08): : 1587 - 1593
  • [22] Clinical impact of drug-drug interactions with systemic azole antifungals
    Bates, DW
    Yu, DT
    DRUGS OF TODAY, 2003, 39 (10): : 801 - 813
  • [23] Patients in Clinical Trials are Sub-Optimally Protected for Drug-Drug Interactions: A Call for Action
    Burger, David
    de Jong, Loek
    van Dijk, Daphne
    Knibbe, Catherijne A. J.
    ter Heine, Rob
    Smolders, Elise
    Pirmohamed, Munir
    JOURNAL OF CLINICAL PHARMACOLOGY, 2024,
  • [24] Drug-drug interactions at hospital admission in geriatric patients in a single facility: a retrospective study
    Sanchez-Arenas, Rosalinda
    Sanchez-Garcia, Sergio
    Garcia-Pena, Carmen
    Juan Garcia-Gonzalez, Jose
    Elsa Rivera-Garcia, Blanca
    Juarez-Cedillo, Teresa
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2012, 50 (06) : 426 - 430
  • [25] Drug-drug interactions in patients using tyrosine kinase inhibitors: A multicenter retrospective study
    Ergun, Yakup
    Ozdemir, Nuriye Yildirim
    Toptas, Serife
    Kurtipek, Alican
    Eren, Tulay
    Yazic, Ozan
    Sendur, Mehmet Ali Nahit
    Akinci, Bulent
    Ucar, Gokhan
    Oksuzoglu, Berna
    Uncu, Dogan
    JOURNAL OF BUON, 2019, 24 (04): : 1719 - 1726
  • [26] Early interventions to detect potential drug-drug interactions on patient eligibility for phase 1 clinical trials
    Azaro, A.
    Ghiglione, L.
    Valdivia, C.
    Munne, M.
    Renedo, B.
    Sabate, N.
    Alcalde, M.
    Brana, I.
    Hierro, C.
    Martin-Liberal, J.
    Ochoa de Olza, M.
    Argiles Martinez, G.
    Vilaro, M.
    Tabernero, J.
    Rodon, J.
    EUROPEAN JOURNAL OF CANCER, 2016, 69 : S42 - S42
  • [27] Drug-drug interactions in patients treated for cancer: a prospective study on clinical interventions
    van Leeuwen, R. W. F.
    Jansman, F. G. A.
    van den Bemt, P. M. L. A.
    de Man, F.
    Piran, F.
    Vincenten, I.
    Jager, A.
    Rijneveld, A. W.
    Brugma, J. D.
    Mathijssen, R. H. J.
    van Gelder, T.
    ANNALS OF ONCOLOGY, 2015, 26 (05) : 992 - 997
  • [28] Clinical significance of potential drug-drug interactions in older adults with psychiatric disorders: a retrospective study
    Liu, Yu
    Yang, Man
    Ding, Yaping
    Wang, Huanqiang
    Zhang, Hailin
    Wang, Dandan
    Zhuang, Tianchi
    Ji, Minghui
    Cui, Yan
    Wang, Hong
    BMC PSYCHIATRY, 2022, 22 (01)
  • [29] Impact of drug-drug interactions on phenobarbital pharmacokinetics in pediatric patients
    Sima, Martin
    Slanar, Ondrej
    EPILEPSIA, 2019, 60 (06) : 1266 - 1267
  • [30] Clinical Relevance of Drug-Drug Interactions in Hospitalized Dermatology Patients
    Ganeva, Maria
    Gancheva, Tanya
    Troeva, Jeni
    Kiriyak, Nataliya
    Hristakieva, Evgenya
    ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE, 2013, 22 (04): : 555 - 563
12345